Diversity and Epitope Spreading of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement
Open Access
- 29 September 2024
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 77 (1) , 67-79
Abstract
Objective: Epitope spreading (ES), involving autoantibodies, plays a crucial role in the development and persistence of autoimmune reactions in various autoimmune diseases. This study aimed to investigate the relationship between ES of anti–RNA polymerase III (RNAP III) antibodies (ARAs) and the clinical manifestations of systemic sclerosis (SSc).Methods: We investigated whether intermolecular ES occurs in the subunits of the RNAP III complex and whether intramolecular ES targets the major antigen, RNA polymerase III subunit A (RPC1), in patients with SSc. To achieve this, we synthesized 17 full‐length subunit proteins of the RNAP III complex and 5 truncated forms of RPC1 in vitro using a wheat germ cell‐free translation system. Subsequently, we prepared antigen‐binding plates and measured autoantibodies in the serum of patients with SSc.Results: Autoantibodies against different RNAP III complex subunits were found in patients who were ARA‐positive with SSc. The intermolecular ES indicators significantly correlated with the modified Rodnan skin thickness score (mRSS) and surfactant protein‐D, a biomarker of interstitial lung disease. However, the extent of disease on high‐resolution computed tomography or pulmonary function tests did not show any significant correlation. Intramolecular ES indicator against RPC1 were significantly correlated with mRSS and renal crisis. Furthermore, longitudinal assessment of ES in RNAP III complex subunits correlated with mRSS and exhibited potential as a disease activity biomarker.Conclusion: Our findings indicate a correlation between ES levels and the severity of skin sclerosis or the risk of other complications in SSc. This study suggests that measuring ES in SSc serves as a novel biomarker for disease activity. imageKeywords
This publication has 53 references indexed in Scilit:
- Systemic Sclerosis-Specific Antibodies: Novel and Classical BiomarkersClinical Reviews in Allergy & Immunology, 2022
- Protective Effect Against Cancer of Antibodies to the Large Subunits of Both RNA Polymerases I and III in SclerodermaArthritis & Rheumatology, 2019
- Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung DiseaseArthritis & Rheumatology, 2019
- Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic ApproachesClinical Reviews in Allergy & Immunology, 2018
- Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti–RNA Polymerase III AutoantibodiesArthritis & Rheumatology, 2014
- Prevalence of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: New Data From a French Cohort and a Systematic Review and Meta‐AnalysisArthritis & Rheumatology, 2013
- B‐cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemiaCancer, 2010
- Enzyme‐linked immunosorbent assay for detection of Anti–RNA polymerase III antibody: Analytical accuracy and clinical associations in systemic sclerosisArthritis & Rheumatism, 2005
- Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: Application to enzyme‐linked immunosorbent assayArthritis & Rheumatism, 2002
- Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexesArthritis & Rheumatism, 1999